PMDA drug package insert
ベクルリー点滴静注用100mg処方せん医薬品かどうか不明（企業未登録）
PMDA Prescription drug · ギリアド・サイエンシズ株式会社 · package insert May 27, 2026
Key facts
| Brand names | ベクルリー点滴静注用100mg処方せん医薬品かどうか不明（企業未登録） |
|---|---|
| Nonproprietary names | レムデシビル |
| Companies | 製造販売元／ギリアド・サイエンシズ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 抗ウイルス剤 |
| Therapeutic category codes | 87625 |
| YJ codes | 6250407D1020 |
| Approval numbers | 30200AMX00455000 |
| Package insert edition | 第12版 |
| Package insert date | May 27, 2026 |
| PMDA document key | 230867_6250407D1020_1 |
| PMDA company code | 230867 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: